Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7417 p307
9 September 2006

This article
Reprint   Photocopy

PDF 40K, Acrobat Reader

Letters

· The Society
· Community pharmacy
· Control of entry
· Complementary medicine
· Controlled drugs
· Diabetes
· Pharmacy in the US


Letters to the Editor

Control of entry

Under pressure

From Mr D. F. Miller, MRPharmS

So now it is official — pharmacists are under pressure (PJ, 19 August, p218). What do we expect?

Since control-of-entry regulations were introduced pharmacists have been denied the opportunity of working independently, to the detriment of the NHS, patients and local communities. Do not take my word for this — look at the Office of Fair Trading report.

Our profession has been commercialised and our standing in the community diminished. While doctors have moved to second in the earnings table we have been relegated to 42nd place. Their corporate masters, whose sole motivation is balance sheet profit, have dumped more and more work on employee pharmacists.

This problem has been exacerbated by our representatives’ support of control-of-entry restrictions. One may argue that their motives are honourable but they are nevertheless misplaced. Maintaining the status quo never makes improvements — all this leads to is complacency and thereby lowering of standards.

The Government is currently reviewing the 2005 legislation and so an opportunity has arisen to reverse its decision to keep the contract restriction — go to www.dh.gov.uk and follow the links to consultations or e-mail gillian.farnfield@dh.gsi.gov.uk (fax 020 7972 2953). This must be done by 12 September 2006.

If all employee pharmacists were to communicate their opinions to the Government, the exploitation reported in the PJ could be prevented. If something is not done soon pharmacy will continue its inextricable decline to the detriment of all.

David Miller
Congleton, Cheshire

Send your letter to The Editor

Previous Topic (Community pharmacy)
Next Topic (Complementary medicine)

Back to Top


©The Pharmaceutical Journal